Key Statistics
Market Cap$1.60B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$3.05
52W High$22.50
52W Low$8.18
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees357
Price Performance
1 Week+5.08%
3 Month-11.32%
1 Year+47.57%
FinancialsAnnual · QuiverQuant
Revenue$76.99M
Assets$355.60M
Liabilities$155.10M
Net Income$143.95M loss
About
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company is headquartered in San Francisco, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze NRIX with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.